Economic Watch: Pharmaceutical multinationals double down on China's biotech innovations
BEIJING, March 27 (Xinhua) -- Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster their global competitiveness. Last week, Lilly's …